Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sintilimab plus gemcitabine + platinum vs placebo in first-line advanced squamous NSCLC
CTR20181437Phase 3Completed
- Sponsor
- Innovent Biologics
- Start
- Sep 2018
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of sintilimab in Pulmonary squamous cell carcinoma, sponsored by Innovent Biologics. Started Sep 2018; status: completed.
02
Drugs
sintilimab
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on CTR20181437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20181437.